Jazz Pharmaceuticals plc buy Truist Financial Co.
Start price
20.03.24
/
50%
€115.00
Target price
20.03.25
€184.14
Performance (%)
-10.61%
Price
26.07.24
€102.80
Summary
This prediction is currently active. The price of Jazz Pharmaceuticals plc has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.61%. This prediction currently runs until 20.03.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 2.646% | 2.646% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $200.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€112.25
04.12.23
04.12.23
€184.92
04.12.24
04.12.24
-10.11%
26.07.24
26.07.24